BHF Kleinwort Benson Group’s Gilead Sciences GILD Stock Holding History

BHF Kleinwort Benson Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-94,824	Closed	-$9.67M	–	389
2015 Q4	$9.67M	Buy	+94,824	New	+$9.87M	0.22%	112
2015 Q3	–	Sell	-148,603	Closed	-$17.4M	–	407
2015 Q2	$17.4M	Buy	148,603 +5,265	+4%	+$575K	0.59%	52
2015 Q1	$14.1M	Sell	143,338 -26,276	-15%	-$2.67M	0.39%	77
2014 Q4	$16M	Sell	169,614 -6,460	-4%	-$668K	0.41%	77
2014 Q3	$18.7M	Sell	176,074 -2,325	-1%	-$228K	0.61%	45
2014 Q2	$14.8M	Sell	178,399 -39,160	-18%	-$3.05M	0.44%	68
2014 Q1	$15.4M	Buy	217,559 +93,421	+75%	+$7.33M	0.45%	70
2013 Q4	$9.32M	Buy	124,138 +104,263	+525%	+$7.26M	0.59%	55
2013 Q3	$1.25M	Buy	19,875 +8,875	+81%	+$530K	0.17%	104
2013 Q2	$540K	Buy	+11,000	New	+$573K	0.07%	151

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BHF Kleinwort Benson Group's GILD Position: Q1 2016 in Review

BHF Kleinwort Benson Group sold out of Gilead Sciences (GILD) in Q1 2016, closing a stake of 94,824 shares — an estimated $9.67M sold.

BHF Kleinwort Benson Group first reported a position in GILD in Q2 2013 and held it in 10 quarters. The position peaked at $18.7M in Q3 2014. 1,630 funds tracked by Wall St. Rank hold GILD as of Q1 2016.

BHF Kleinwort Benson Group reported no remaining Gilead Sciences position as of Q1 2016 after selling out during the quarter.
BHF Kleinwort Benson Group sold 94,824 Gilead Sciences shares in Q1 2016, an estimated $9.67M.
BHF Kleinwort Benson Group first reported a position in Gilead Sciences in Q2 2013 and held it in 10 quarters.
BHF Kleinwort Benson Group's Gilead Sciences position peaked at $18.7M in Q3 2014.
1,630 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2016.

Based on BHF Kleinwort Benson Group's 13F filing for Q1 2016, filed 9 May 2016.